Christopher Yea, CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 4,347 shares at $15.57 ($68K) on 2026-02-23, disclosed to the SEC on 2026-02-24.
Seasonal sale ($68k) by CHIEF DEVELOPMENT OFFICER — this insider has traded KALV in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| KALV | SELL | 2026-05-26 | $63K | — | Filing → |
| KALV | SELL | 2026-05-19 | $30K | — | Filing → |
| KALV | SELL | 2026-02-19 | $17K | — | Filing → |